Table 4.
WE |
CE |
DE |
||||
This Study |
Literature Reports |
This Study |
Literature Reports |
This Study |
Literature Reports |
|
Mole | ||||||
Total moles, μmol/mg meibum | 0.77 ± 0.07 | Not reported | 0.56 ± 0.03 | Not reported | α,ω Type II: 0.034 ± 0.003 | Not reported |
ω Type I-St: 0.039 ± 0.004 | ||||||
Saturated, % | 15 ± 1 | Not reported | 76 ± 2 | 4:1 (saturated: unsaturated)55 | α,ω Type II: 0 ω Type I-St: 9 ± 1 | Not reported |
Unsaturated, % | 85 ± 1 | Not reported | 24 ± 1 | α,ω Type II: 100 | Not reported | |
ω Type I-St: 91 ± 3 | ||||||
Mass | ||||||
Total meibum lipids, % | 48 ± 4 | 34.964 | 40 ± 2 | 29.504 | α,ω Type II: 3.4 ± 0.1 | Not reported |
51.1 ± 3.62 | 39.4 ± 3.12 | ω Type I-St: 4.3± 0.1 | ||||
41 ± 856 | 3132 | sum: 7.7 ± 0.1 | 2.3 ± 0.82 | |||
25.2 ± 2.68 | 66.8 ± 3.48 | 8.374 | ||||
Saturated, % | 14 ± 1 | 18 ± 256 | 75 ± 2 | 77.224 | α,ω Type II: 0 | Not reported |
ω Type I-St: 9 ± 1 | ||||||
Unsaturated, % | 86 ± 1 | 82 ± 256 | 25 ± 1 | 21.52 (1.26 unidentified)4 | α,ω Type II: 100 | Not reported |
ω Type I-St: 91 ± 3 |